MiNK Therapeutics Inc. (INKT) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for MiNK Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
MiNK Therapeutics Inc. (INKT) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $54M. It trades at $10.80, up 1.60% today. 2 analysts' average target of $42.50 implies +293.5% from today's price. Kronos AI's 30-day forecast is +10.9% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $42.50 |
| Low – high | $35.00 – $50.00 |
| Analysts | 2 |
| Upside to average | +293.5% |
Kronos AI 30-day forecast
| Expected close | $11.79 (+10.9%) |
| Likely range | +3.5% … +14.9% |
| As of | 2026-10-27 |
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator